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a b s t r a c t
Endocytosis plays an important role in the regulation of tumour growth and metastasis. In Drosophila, a
number of endocytic neoplastic tumour suppressor genes have been identiﬁed that when mutated cause
epithelial disruption and over-proliferation. Here we characterise the Drosophila homologue of the Rab5
effector Rabaptin-5, and show that it is a novel neoplastic tumour suppressor. Its ability to bind Rab5 and
modulate early endosomal dynamics is conserved in Drosophila, as is its interaction with the Rab5 GEF
Rabex5, for which we also demonstrate neoplastic tumour suppressor characteristics. Surprisingly, we do
not observe disruption of apico-basal polarity in Rabaptin-5 and Rabex-5 mutant tissues; instead the
tumour phenotype is associated with upregulation of Jun N-terminal Kinase (JNK) and Janus Kinase
(JAK)/Signal Transducer and Activator of Transcription (STAT) signalling.
& 2013 The Authors. Published by Elsevier Inc. All rights reserved.
Introduction
The endocytic pathway inﬂuences many developmental pro-
cesses including signalling, tissue morphogenesis and cell polarity.
Although the endocytic process has been described in great detail
in the mammalian cell culture, in vivo analysis of its speciﬁc
developmental roles has been complicated by the essential and
constitutive requirement for endocytosis in most cell types, and
there remains much to be understood.
In Drosophila, many endocytic components have been found to
function as neoplastic tumour suppressor genes (reviewed in
Vaccari and Bilder (2009)). Loss of function mutations in these
genes cause epithelial tissues to over-proliferate, differentiation to
be lost and normal tissue architecture including apico-basal
polarity, to be disrupted (Herz et al., 2009, 2006; Lu and Bilder,
2005; Menut et al., 2007; Moberg et al., 2005; Morrison et al.,
2008; Rodahl et al., 2009; Thompson et al., 2005; Vaccari and
Bilder, 2005; Vaccari et al., 2009).
Endocytic genes can be grouped into two categories with
slightly different tumour phenotypes, according to whether the
gene acts early or late in the endocytic pathway. Endocytic tumour
suppressor genes such as Rab5, the syntaxin Avalanche (Avl) and
the Rab5 effector Rabenosyn-5 (Rbsn-5), act at the level of early
endosome fusion (Gorvel et al., 1991; Lu and Bilder, 2005;
Morrison et al., 2008; Nielsen et al., 2000). Despite the tumour
phenotype of tissue wholly mutant for these genes, clones of
mutant cells in an otherwise wild-type background do not over-
grow and instead tend to become out-competed by wild-type cells
and eliminated from the tissue (Lu and Bilder, 2005). Work in
other tumour suppressor mutants in which the phenomenon was
ﬁrst observed, indicates that this probably occurs through a JNK-
dependent apoptotic response, which after clone elimination
allows tissues to resume their wild-type pattern of growth and
development (Agrawal et al., 1995; Brumby and Richardson, 2003;
Igaki et al., 2006, 2009; Ohsawa et al., 2011; Uhlirova et al., 2005).
However, a second group of tumour suppressor genes, which act
later in the endocytic pathway, exhibit a non-autonomous tumour
phenotype whereby mutant clones have the ability to promote
growth in adjacent wild-type tissue (Herz et al., 2006, 2009;
Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder,
2005; Vaccari et al., 2009; reviewed in Herz and Bergmann
(2009)). These encode some of the components of the ESCRT
(endosomal sorting complexes required for transport) complex,
which functions in the formation of multivesicular bodies (MVBs,
reviewed in Jouvenet (2012)). The difference between these two
types of endocytic tumour seems to be due to their differential
effects on Notch (N) signalling, caused by ectopic accumulation of
N protein at different points of the endocytic pathway, depending
upon where the endocytic block occurs (Herz et al., 2006, 2009; Lu
and Bilder, 2005; Moberg et al., 2005; Morrison et al., 2008;
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Thompson et al., 2005; Vaccari and Bilder, 2005; Vaccari et al.,
2008). In general, whilst lack of N internalisation in early endocy-
tic mutants does not appear to promote signalling (Lu and Bilder,
2005; Morrison et al., 2008; Vaccari et al., 2008), blockage of entry
into MVBs in ESCRT mutants causes N signalling to be ectopically
activated, resulting in transcription of the secreted JAK/STAT ligand
Unpaired (Upd), which acts as a transforming factor to promote
growth in adjacent wild-type tissue (Herz et al., 2006, 2009;
Moberg et al., 2005; Thompson et al., 2005; Vaccari and Bilder,
2005; Vaccari et al., 2008).
Neoplastic tumour phenotypes were ﬁrst observed in mutants
for lethal giant larvae (lgl), discs large (dlg) and scribble (scrib),
components of the baso-lateral septate junction complex that is
required to regulate apico-basal polarity of epithelial cells
(Agrawal et al., 1995; Bilder et al., 2000; Bilder and Perrimon,
2000; Bryant and Schubiger, 1971; Gateff, 1978; Gateff and
Schneiderman, 1967; Woods and Bryant, 1989; reviewed in
Ellenbroek et al. (2012); Enomoto and Igaki, 2011). Various
experiments indicate that over-expression of apical proteins such
as Crumbs (Crb) or atypical protein kinase C (aPKC) can expand the
apical domain, resulting in loss of apico-basal polarity and sub-
sequent induction of neoplasia (Bilder and Perrimon, 2000; Leong
et al., 2009; Wodarz et al., 1995). This has been proposed as a
mechanism for tumourigenesis in the endocytic mutants, as Crb
has been shown to accumulate abnormally in endocytic tumours
(Lu and Bilder, 2005; Moberg et al., 2005; reviewed in Vaccari and
Bilder (2009)). However, it is clear that compromising endocytosis
will lead to abnormal trafﬁcking of components of many develop-
mental pathways and hence the aetiology of neoplastic tumour
formation is likely to be complex.
Although at least 14 endocytic tumour suppressor genes have
already been identiﬁed in Drosophila, screens have not been
saturating and it is likely that many remain undiscovered. Here
we describe a previously uncharacterised neoplastic tumour
suppressor gene: the Drosophila homologue of Rabaptin-5, which
we initially found in a screen to identify novel genes involved in
planar polarity (Helen Strutt, Vickie Thomas-MacArthur, CT and
DS, unpublished data). Rabaptin-5 is a Rab5 effector protein that
has been shown to physically interact with activated Rab5 and
promote homotypic early endosome fusion in the mammalian
tissue culture (Horiuchi et al., 1997; McBride et al., 1999; Stenmark
et al., 1995; Vitale et al., 1998). The latter function of Rabaptin-5 is
mediated through formation of a complex with the Rab5 guanine
nucleotide exchange factor (GEF) Rabex-5, which acts to increase
nucleotide exchange on Rab5, enhancing its activity and hence its
ability to recruit other effectors involved in the endosomal fusion
process (Horiuchi et al., 1997; Lippe et al., 2001). In addition to
Rabex-5, a large number of other binding partners for Rabaptin-5
have been characterised to date, and it appears that it can act
divalently to bridge different trafﬁcking pathways. For example,
through interacting with both Rab5 and Rab4 it mediates the
transfer of cargo from early endosomes back to the plasma
membrane through the fast recycling pathway (Daro et al., 1996;
van der Sluijs et al., 1992; Vitale et al., 1998). Unlike most of the
endocytic tumour suppressor genes so far identiﬁed, Rabaptin-5
has been implicated in human cancers, (Christoforides et al., 2012;
Magnusson et al., 2001; Wang et al., 2009; Xiao et al., 1997), and
thus the Drosophilamutant may represent a valuable model for the
study of human tumourigenesis.
We ﬁnd that several functions of Rabaptin-5 are conserved in
Drosophila, including its GTP-dependent binding of Rab5, its ability
to modulate endosomal dynamics and its interaction with Rabex-
5. Our work suggests that Drosophila Rabex-5 is also a neoplastic
tumour suppressor gene and that the tumour phenotype of both
mutants is associated with ectopic activation of JNK and JAK/STAT
pathways.
Materials and methods
Drosophila stocks and genetics
The following Drosophila stocks were used; From Bloomington
stock centre (described in FlyBase):MS1096-GAL4, 459.2-GAL4, ptc-
GAL4, pnr-GAL4, UAS-Dcr2, cnbwsp, P{ryþΔ(2–3)}, Ubx-FLP, FRT42D
P{arm-lacZ}, P{arm-lacZ} FRT80B, P{EPgy2}CG4030EY21320 (a P-
element insertion in Rbpn5 3′UTR), Df(2R)F36 (a deﬁciency unco-
vering Rbpn5) and Df(3L)BSC250 (a deﬁciency uncovering Rabex-5).
P{GD11194}v26367 and P{GD14133}v46329 are RNAi lines (VDRC).
10xSTAT-GFP (Bach et al., 2007), Gbe-Su(H)-lacZ (Furriols and Bray,
2001) and pucE69 (Martín-Blanco et al., 1998) are reporter lines
(gifts from Martin Zeidler). ex-lacZ is a reporter line (a gift from
Barry Thompson and Boedigheimer and Laughon, 1993). stat92EF is
a hypomorph (Baksa et al., 2002). Rabex-5ex42 is a hypomorph (a
gift from Cathie Pﬂeger, Yan et al., 2010). Transgenes used were
UAS-Rabex-5:Myc and UAS-Rabex-5DPYT:Myc (gifts from Cathie
Pﬂeger and Yan et al., 2010), UAS-YFP-Rab5S43N (Bloomington and
Zhang et al., 2007). UAS-Rbpn-5 was constructed by insertion of
the Rbpn-5 coding region from the cDNA clone LD23155 (BDGP)
into pUASt (Brand and Perrimon, 1993). pWIZ-Rbpn-5 is an RNAi
line with no predicted off-targets and no homology to existing
VDRC RNAi lines made by double inverted cloning of a 312 bp
fragment of Rbpn-5 into the pWIZ vector (Lee and Carthew, 2003)
using the following primers:
LeftRNAiCG4030þXbaI:
GCATCTAGACACACCTAATGGTGGCG
RightRNAiCG4030þXbaI:
GCTCTAGAAAGCTGCTGTTCAGGGAG
Transgenics were generated by BestGene.
RNAi screen
An in vivo RNAi screen was carried out using approximately
10,000 lines from Vienna Drosophila Research Centres (VDRC) and
National Institute of Genetics (NIG) (Helen Strutt, Vickie Thomas-
MacArthur, CT and DS, unpublished data). In brief, genes to be
screened were pre-selected by FlyBase gene ontology, Interpro
predicted protein domains and likely expression in the wing as
predicted by microarray analysis (Ren et al., 2005). The MS1096-
GAL4 driver was chosen for initial screening due to its strong and
relatively speciﬁc expression pattern in the Drosophila wing
(Capdevila and Guerrero, 1994), with the 459.2-GAL4 driver used
for secondary screening (both Bloomington). Screening was car-
ried out at 29 1C and 25 1C. Adult wings were mounted in GMM
mountant and scored for planar polarity defects.
Generation of the Rbpn-5 mutant
Male P-element mediated meiotic recombination was carried
out as previously described (Preston et al., 1996), in ﬂies carrying
both the transposase P{ryþΔ(2–3)} and the P{EPgy2}
CG4030EY21320 element, using cn and bw ﬂanking markers for
directional selection of recombination events. A small deletion,
named CG4030Del1, was generated encompassing CG4030, CG4038
and CG34396 (sequence location 2R:16,976,092…16,989,307) and
was found to be lethal if homozygous or transheterozygous with
the larger deﬁciency Df(2R)F36.
In order to rescue the entire CG4030Del1 deletion, the 33 kb
attB-P[acman]CH322-86L04 construct was obtained from BACPAC
Resources and injected by Genetivision into the P2(3L)68A4 site via
a ΦC31 transposase-mediated transgenesis. Rescued ﬂies were
viable and appeared wild-type. Recombineering was used to
generate a mutant form of attB-P[acman]CH322-86L04 lacking
the CG4030 protein coding region, using methods based on those
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described by the Bellen lab (Venken et al., 2006 and protocols at
www.pacmanﬂy.org/protocols.html). The following oligos were
used to amplify the loxP cassette from PL452N-EGFP:
RightCG4030armþLoxPR: TGCATGGCTCGCCTTTGAATTAAACA-
ACTCAATTCATTACTTTGATATCAACTAGTGGATCCCCTCGAGGGAC
LeftCG4030armþLoxPF: TCGGTATTATTCAAATATGGTAACACCA-
AGAGCAGTGTTGAAAATCGCTCTCGGCATGGACGAGCTGTAC
The PCR fragment was recombineered into attB-P[acman]
CH322-86L04 and the loxP cassette was then ﬂipped out to create
attB-P[acman]CH322-86L04-ΔCG4030. The construct was veriﬁed
by sequencing and injected by Genetivision into the P2(3L)68A4
site via the ΦC31 transposase-mediated transgenesis. Transgenic
ﬂies were used to create the following genotype for analysis of the
Rbpn-5 mutant phenotype: w; FRT42 CG4030Del1; attB-P[acman]
CH322-86L04-ΔCG4030/SM6a:TM6b
Antibodies and immunohistochemistry
The following primary antibodies were used for immunolabel-
ling: 1:50 rabbit anti-Rab5 (a gift from Marcos Gonzalez-Gaitan)
(Wucherpfennig et al., 2003), 1:4000 rabbit anti-EGFP (Molecular
Probes), 1:4000 rabbit anti-ß-Gal (Cappel), 1:1000 mouse anti-
Flamingo (DSHB) (Usui et al., 1999), 1:300 rabbit anti-Frizzled
(Bastock and Strutt, 2007), 1:1000 rat anti-Strabismus (Strutt and
Strutt, 2008), 1:25 rat anti-Prickle (Strutt et al., 2013), 1:200 mouse
anti-Armadillo N27A1 (DSHB) (Peifer et al., 1994), 1:20 rat anti-E-
Cadherin (DSHB) (Oda et al., 1994), 1:250 guinea pig anti-Bazooka
(a gift from Jennifer Zallen, and Wodarz et al., 1999), 1:100 mouse
anti-Discs large 4F3 (DSHB) (Parnas et al., 2001), 1:500 rabbit anti-
nPKC-zeta (cross reacts with Drosophila aPKC, Santa Cruz), 1:5
mouse anti-Crumbs Cq4 (DSHB) (Tepass et al., 1990), 1:200 rat
anti-Elav 9F8A9 (DSHB), 1:50 mouse anti-Mmp1 catalytic domain
5H7B11 (DSHB) (Page-McCaw et al., 2003), 1:20 mouse anti-Notch
(DSHB, a gift from Sarah Bray, and Fehon et al., 1991), 1:25 mouse
anti-Myc 9E10 (Shefﬁeld BioServe), 1:100 rabbit anti-Active JNK
(Promega) and 1:1000 rabbit anti-Histone H3 (phospho S10)
(Abcam).
To make anti-Rbpn-5, the ﬁrst 750 bp of the Rbpn-5 coding region
was cloned into the pGEX-6P-1 vector and expressed in E.coli. Soluble
GST-Rpbn-5 antigen was puriﬁed on a Gluthathione Sepharose 4B
column (GE Healthcare) and the GST tag was removed using
PreScission Protease (Carl Smythe). 0.5 μg antigen was injected into
each of three rats and serum from ﬁnal bleeds was collected and
used at 1:500 for immunohistochemistry. Secondary antibodies used
were anti-rabbit, -rat, -mouse and -guinea pig Cy2, Alexa568 and Cy5
from Jackson and Molecular Probes.
For pupal wing dissection, white prepupae were collected and
aged at 29 1C. Early pupal wings were dissected at 4.5 h after
puparium formation (APF), when protein localisation is dynamic
and cells are dividing, rearranging and changing shape, whereas
late pupal wings were dissected at 26 h APF, a time point just
before trichome formation when localisation of core planar polar-
ity proteins is at its most asymmetric (Aigouy et al., 2010; Classen
et al., 2005; Strutt and Strutt, 2009). Imaginal discs were taken
from wandering 3rd instar larvae. Immunolabellings of imaginal
discs and pupal wings were carried out as previously described
(Strutt, 2001).
GST pulldown assays
The coding regions of Drosophila Rab4, Rab5, Rab5Q88L,
Rab5N43S, Rab7, Rab8, Rab11, Rab23 and Rabex5 were individually
cloned into the pGEX-6P-1 vector. GST-Rab proteins were
expressed in E.coli, extracted from pelleted cells and bound to
Glutathione Sepharose 4B beads (GE Healthcare) for 30 min at
4 1C in a buffer containing 50 mM Tris, pH 7.5, 50 mM NaCl, 5 mM
MgCl2, and protease inhibitors. Beads were then incubated with
GTP or GDP if required, for 90 min at room temperature in loading
buffer containing 20 mM Hepes, 100 mM NaCl, 0.5 mM MgCl2,
2 mM EDTA, 0.05% CHAPS, 1 mM DTT and protease inhibitors.
EGFP-Rbpn-5 was cloned into the pAc5.1 vector (Invitrogen).
The Rbpn-5 fragments Rbpn-5N (amino acids 1–345) and Rbpn-5C
(amino acids 340–642) were made by removal of the unwanted
half of the gene from pAc5.1-EGFP-Rbpn5 by restriction digestion,
making use of the unique XhoI site halfway through the Rbpn-5
coding region. For Rbpn-5N a linker was added containing a STOP
codon. Gene fragments were EGFP-tagged and inserted into
pAc5.1. Vectors were transfected into Drosophila S2 cells. Cell
lysate was extracted 48 h after transfection and added to the
freshly prepared Gluthathione Sepharose 4B beads. Beads were
incubated for 2 h at 4 1C buffer, then washed in buffer containing
250 mM NaCl to remove non-speciﬁcally bound proteins. Beads
were loaded directly onto 10% acrylamide gels after denaturing at
95 1C for 3 min and Western blots were carried out using 1:4000
rabbit anti-EGFP (Abcam) or 1:5000 rat anti-Rbpn-5. Secondary
antibodies used were anti-rat and -rabbit HRP (Dako) and signal
was detected using Supersignal West Dura (Thermo Scientiﬁc).
Microscopy, image presentation and statistical analysis of puncta
data
Fluorescent images were collected on an Olympus FV1000
confocal. Bright-ﬁeld adult wing and notum photographs were
taken using the ProgResC14 camera system from Jenoptik on a
Leica DMR upright microscope. Images were processed in ImageJ
and ﬁgures constructed using Adobe Photoshop.
For Rab5 puncta analysis, a Z stack of 0.15 μm slices at 60
magniﬁcation with 3 zoom (0.069 μm per pixel) was obtained
and slices were maximally projected in ImageJ as follows. Apical
was deﬁned as the three most apical in focus slices (roughly
0.5 μm thickness), whereas subapical was deﬁned as the next
0.5 μm (slices 4–6). To get a value for total Rab5 (Fig. 4G), the top
10 slices were projected. Projected images were thresholded in
ImageJ using the Triangle function and particles were analysed for
their number, average size and total area in identically sized wild-
type and mutant areas of the wing. T-tests were used to calculate
statistical signiﬁcance. Mutant values were normalised against
wild-type values within each wing to make graphs. Data was
compiled and statistically analysed using the Microsoft Excel.
Results
A screen for genes involved in planar polarity identiﬁes the drosophila
homologue of Rabaptin-5
We performed an in vivo RNAi screen in the Drosophila wing to
look for novel genes involved in planar polarity (Helen Strutt,
Vickie Thomas-MacArthur, CT and DS, unpublished data). An RNAi
line targeting CG4030 showed a phenotype of mild wing trichome
swirling, together with mild veining defects (VDRC line GD26367,
Fig. S1B). CG4030 is predicted to encode a Rab5 binding protein
with homology to Rabaptin-5 (Fig. 1A). Blast alignment indicates
that CG4030 is likely to be the Drosophila Rabaptin-5 homologue
(abbreviated here to Rbpn-5); protein homology is particularly
high in the C-terminal region, which contains the putative Rab5
binding domain (NCBI Blast alignment score of 91.7), and is less
conserved in the N-terminal region (NCBI Blast alignment score of
39.7). Unlike vertebrate Rabaptin-5 proteins, Drosophila Rbpn-5 has a
FYVE (Fab1,YOTB/ZK632.12,Vac1 and EEA1) domain at its extreme
C-terminus. FYVE domains target proteins to endosomal mem-
branes through binding to phosphatidylinositol 3-phosphate (PI3P),
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a lipid that is enriched on endosomal membranes (Burd and Emr,
1998; Stenmark et al., 1996). The Rbpn-5 FYVE domain appears to
be conserved in many invertebrates, indicating that it may have
been lost at some point in the vertebrate lineage (data not shown).
Interestingly, another Rab5-interacting, FYVE domain-containing
protein, EEA1, is not found in arthropods, although is present in
other invertebrates such as nematodes. However, sequence analy-
sis suggests that Drosophila Rbpn-5 is only indirectly related to
mammalian EEA1 through its FYVE domain and hence they are not
likely to be orthologous (Fig. S1G).
To conﬁrm the RNAi phenotype and check that the planar
polarity phenotype was not due to an off-target effect, we made a
Fig. 1. The Drosophila homologue of Rabaptin-5 is a novel endocytic neoplastic tumour suppressor gene. (A) A cartoon of the human (isoform A) and Drosophila Rabaptin-5
proteins indicating functional domains determined experimentally for human Rabaptin-5 (Mattera et al., 2006; Vitale et al., 1998) and predicted by sequence homology for
Drosophila Rbpn-5 (NCBI Conserved Domains). In Drosophila Rabaptin-5, the Rabex-5 and Rab4 binding domains are hypothetical and determined by BLAST of the equivalent
domains in the human Rabaptin-5—BLAST scores are low (o40) for both. Rab5 binding domain (red), Rabex-5 binding domain (blue), Rab4 binding domain (green), FYVE
domain (yellow). (B) Wild-type and Rbpn-5 homozygous mutant pupae. The Rbpn-5 mutant larvae grow considerably larger during extended larval stages, and die shortly
after pupation. (C) Wild-type (C) and Rbpn-5 homozygous mutant (C′) wing discs stained for Dlg. Scale bars are 100 μm long in both. Rbpn-5 mutant tissue proliferates
excessively to create a highly folded and disrupted epithelium. (D-E) Wild-type (D) and Rbpn-5 homozygous mutant (E) eye discs stained for aPKC, Mmp1 and Elav.
Differentiation is abnormal and Mmp1 levels are increased in the Rbpn-5 mutant. Anterior is to the left. Scale bar is 50 μm long in both. (F-I) Wing discs stained with aPKC in
red (apical), E-Cad in blue (junctional) and Dlg in green (baso-lateral) in wild-type (F,H) or Rbpn-5mutants (G,I). Although cells have a larger apical surface in Rbpn-5mutants
than in wild-type (F-G), apico-basal polarity markers localise correctly at cell edges and show clear separation in a lateral view (H-I). In the wild-type (H), two apical surfaces
are apposed in a fold of the wing disc, in the mutant (I), only a single apical surface is seen in an abnormal fold. Scale bars are 5 μm long in F–I. (J) Wildtype (J) and Rbpn-5
homozygous mutant (J′) eye discs stained for Crb. Laser power and gain was kept at the same level for both images. Scale bars are 10 μm long. (K-L) Localisation of markers is
normal in Rbpn-5 mutant clones visualised in wings at 28 h APF. E-Cad is green and aPKC is red in K, Fmi is green and Baz is red in L. Clones are marked by absence of β-Gal
staining (blue). Scale bars are 10 μm long in K and L.
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separate pWIZ-Rbpn-5 RNAi line targeting an independent
sequence within the Rbpn-5 gene with no predicted off-targets.
This produced a phenotype of wing trichome swirling with
frequent multiple trichomes produced per cell, in addition to mild
wing veining defects and wing unevenness (Fig. S1C). We also
analysed the effect of RNAi expression in the notum using the
pannier-GAL4 (pnr-GAL4) driver. GD26367 RNAi-Rbpn-5 expression
disrupts the polarity of microchaetae and trichomes in the notum,
whereas pWIZ RNAi-Rbpn-5 expression causes loss of microchaetae
in addition to trichome polarity and spacing defects (Fig. S1E-F).
These pleiotropic results suggest that Rbpn-5 acts in multiple
processes.
Rbpn-5 is a neoplastic tumour suppressor gene
In order to analyse the function of Rbpn-5 in more detail, we
removed gene activity entirely using a small deletion of the Rbpn-5
gene region combined with p[acman] mediated rescue of ﬂanking
genes (see Section Materials and methods). Rbpn-5 mutants have
an extended larval stage (approximately doubled compared with
wild-type at 25 1C) in which they grow signiﬁcantly larger than
wild-type larvae, before dying shortly after pupation (Fig. 1B). This
‘giant larvae’ phenotype is reminiscent of that seen in neoplastic
tumour suppressor mutants, a subgroup of which correspond to
mutations in genes encoding endocytic proteins including Rab5
itself and another Rab5 binding protein, Rbsn-5 (Lu and Bilder,
2005; Morrison et al., 2008).
To test whether Rbpn-5 might be a novel neoplastic tumour
suppressor gene, we examined wing and eye imaginal discs from
Rbpn-5 giant larvae. Discs are variable in size and many are no
larger than wild-type discs, however, tissue structure is disrupted
and the epithelium is highly overgrown and folded in on itself
(Fig. 1C′,E). In addition, cell size appears to be variable, and many
cells are extremely enlarged compared to wild-type (Fig. 1F-G).
Neoplastic tumours are characterised by their absence of differ-
entiation, disrupted apico-basal polarity and their upregulation of
Matrix metalloprotease 1 (Mmp1), a target of JNK signalling
involved in extracellular matrix remodelling, which is a marker
for tumour metastasis (Beaucher et al., 2007; Page-McCaw et al.,
2003; Srivastava et al., 2007; Uhlirova and Bohmann, 2006).
Staining of eye discs with the neuronal marker Elav indicated that
ommatidial differentiation does occur to some extent, but is not
properly spatially regulated within the disc and differentiated cells
appear abnormal in size and shape (Fig. 1E). Strong upregulation of
Mmp1 levels was also seen, particularly in non-differentiated
regions of the disc, indicating that tumours are likely to possess
metastatic ability (Fig. 1E).
We examined the localisation of a large number of markers for
apico-basal polarity, planar polarity and adherens junctions
(Figs. 1F–J, S2A–F and not shown), all of which show a largely
wild-type localisation pattern despite the disruption to tissue
organisation. Unlike as described for other neoplastic tumour
suppressors (Lu and Bilder, 2005; Menut et al., 2007; Moberg
et al., 2005; Morrison et al., 2008; Rodahl et al., 2009; Vaccari and
Bilder, 2005), it appears that apico-basal polarity is conserved in
Rbpn-5 mutants, as we saw clear separation of markers for apical
(aPKC) and baso-lateral (Dlg) membrane domains (Fig. 1H-I). Loss
of apico-basal polarity in other endocytic neoplastic tumour
suppressor mutants has been proposed to occur through an
expansion of the apical domain caused by a failure to endocytose
the apical determinant Crb (Lu and Bilder, 2005; Moberg
et al., 2005; reviewed in Vaccari and Bilder, 2009). To test
whether localisation of Crb was affected in Rbpn-5 mutants, we
stained discs for Crb protein (Fig. 1J). Surprisingly, we do not see
any signiﬁcant accumulation of Crb in mutant discs compared to
wild-type discs, suggesting that tumour formation can occur even
when apico-basal polarity is not signiﬁcantly disrupted.
A feature of neoplastic tumour suppressor genes is that clones
of mutant cells surrounded by wild-type tissue do not overgrow,
and in fact often proliferate less than the surrounding tissue
(Agrawal et al., 1995; Brumby and Richardson, 2003; Igaki et al.,
2006, 2009; Lu and Bilder, 2005; Ohsawa et al., 2011; Uhlirova
et al., 2005). We generated mitotic clones of Rbpn-5 in Drosophila
pupal wings using the FLP/FRT system and Ubx-FLP. Rbpn-5mutant
clones are viable and behave in a very similar way to wild-type
cells, neither obviously over- nor under-proliferating. Moreover, no
defects were seen in these clones compared to wild-type tissue
when stained with a series of markers (Fig. 1K-L and not shown).
In summary, these results suggest that Rbpn-5 is a novel neoplastic
tumour suppressor gene that displays both similarities to and
differences from neoplastic tumour suppressor genes already
characterised.
Drosophila Rbpn-5 binds to Rab5
Mammalian Rabaptin-5 is considered to be an effector of Rab5
as it binds to it in a GTP-dependent manner in order to mediate
certain functions including Rab5 recruitment and early endosome
fusion (Stenmark et al., 1995). To test whether this function might
be conserved in Drosophila, we carried out GST pulldowns to look
for binding between Rbpn-5 and various Drosophila Rab GTPases.
We found that as in vertebrates, Drosophila Rbpn-5 binds to Rab5
in the presence of GTP, or to an activated form of Rab5, but does
not bind to Rab5 in the presence of GDP or to a dominant-negative
form of Rab5 (Fig. 2A-B). To test where in the Rbpn-5 protein Rab5
might bind, we split Rbpn-5 into N- and C-terminal fragments (see
Materials and Methods) and found as expected that Rab5 binds to
the C-terminal part of Rbpn-5 (containing the predicted Rab5-
binding domain) and not to the N-terminal fragment (Fig. 2C). We
did not observe binding of Rbpn-5 to any other Rab protein tested
including Rab4, Rab7, Rab11, Rab8 or Rab23 (Fig. 2B and data not
shown). The absence of binding to Rab4 is surprising, since
mammalian Rabaptin-5 does bind to Rab4 in a GTP-dependent
manner to provide a link between endocytosis and the fast
recycling pathway (Daro et al., 1996; Deneka et al., 2003; Pagano
et al., 2004; van der Sluijs et al., 1992; Vitale et al., 1998). The
putative Rab4 binding domain is in the N-terminal half of
Rabaptin-5 (Vitale et al., 1998), which appears to be less highly
conserved in invertebrates. This result mirrors that seen with
Rbsn-5, another Rab5 effector whose mammalian homologue
binds to Rab4 in vertebrate cells, but whose Drosophila homologue
does not (de Renzis et al., 2002; Morrison et al., 2008; Nielsen
et al., 2000), suggesting that the fast recycling pathway may not be
regulated in the same manner in Drosophila as it is in mammalian
cells.
Drosophila Rbpn-5 modulates early endosome dynamics in vivo
We raised an antibody against Drosophila Rbpn-5 (see Materials
and Methods) and observed its localisation in pupal wings. Rbpn-5
is uniformly expressed and localises to punctate apical structures
together with some cytoplasmic staining deeper within the cell
(Fig. 3A–C). The punctate staining co-localises well with an anti-
body against Rab5, indicating that these vesicles are probably early
endosomes. As previously found (Mottola et al., 2010), Rab5
puncta appear to be enriched apically: this is most striking in
early pupal wings (4.5 h after puparium formation at 29 1C), but
can also be observed in third instar larval wing discs and later
stage pupal wings (26 h APF at 29 1C, Fig. 3A-B and data not
shown).
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Use of the patched-GAL4 (ptc-GAL4) driver to express RNAi-
Rbpn-5 in a stripe anterior to the L4 wing vein, indicated that RNAi
using either dsRNA construct is extremely effective in reducing the
levels of Rbpn-5 protein (Fig. 3D and data not shown). Interest-
ingly, RNAi expression signiﬁcantly reduces the number and size of
apical Rab5 puncta, but has no effect on puncta observed just
subapical to the surface (0.5 μm below, Fig. 3D,G). A similar
effect is seen in Rbpn-5 loss-of-function clones (Fig. 3E). This
suggests that Rbpn-5 is involved in promoting apical localisation
of Rab5 and hence is probably involved in regulating Rab5-
mediated endocytosis from the apical surface.
We also made constructs to over-express Rbpn-5 under control
of the UAS promoter. In mammalian cells, it has been shown that
transfection of Rabaptin-5 results in excessive homotypic early
endosome fusion, resulting in a characteristic enlarged early
endosome phenotype (Stenmark et al., 1995). We observed a much
more subtle phenotype in the Drosophila wing, whereby the
number and size of subapical early endosomes is slightly, but
signiﬁcantly increased (Fig. 3F,H). However, we did also observe a
slight reduction in the numbers of apical early endosomes. These
results taken together suggest that in Drosophila, Rbpn-5 is
necessary to promote normal levels of early endosome fusion,
but is not sufﬁcient to enhance the process by more than a very
small amount, possibly due to limiting quantities of other proteins
involved in early endosome fusion.
If a lack of Rbpn-5 signiﬁcantly inﬂuences early endosome
dynamics, then we would expect to see defects in the localisation
of proteins that are normally endocytosed through this pathway.
To this end, we examined a large number of markers in pupal
wings expressing RNAi-Rbpn-5 under the ptc-Gal4 driver and
compared them to adjacent wild-type cells. However, we were
unable to ﬁnd signiﬁcant differences in localisation of any protein
examined including those involved in apico-basal polarity or
planar polarity, either in early or late pupal wings (Fig. S3 and
data not shown). This suggests that despite the reduction in apical
Rab5-positive vesicles, a sufﬁcient level of endocytosis for normal
function is still present in RNAi-Rbpn-5 expressing tissue.
Drosophila Rbpn-5 and Rabex-5 interact to modulate early endosome
dynamics
In vertebrates, Rabaptin-5 acts to recruit activated Rab5 to
endocytic sites through binding to and enhancing the activity of
Rabex-5, a GTP exchange factor (GEF) that converts inactive GDP
bound Rab5 to the active GTP bound form (Esters et al., 2001;
Horiuchi et al., 1997). To test whether this interaction might be
conserved in Drosophila, we carried out GST pulldowns between
Rbpn-5 and the Drosophila homologue of Rabex-5, and found that
the two proteins interact physically (Fig. 4A). Mammalian Rabex-5
binds to a coiled-coil region in the third quarter of Rabaptin-5
(Mattera et al., 2006), which has homology to the central region of
Rbpn-5 (Fig. 1A). Since this domain is split between the N- and C-
terminal halves of Rbpn-5 that we previously generated, we did
not anticipate that Rabex-5 would be able to pull down either half
individually, and indeed we could not demonstrate binding to
either fragment (data not shown).
In vitro assays have shown that Rabaptin-5 requires Rabex-5
both for its recruitment to early endosomes and its ability to
promote early endosome fusion, whereas Rabex-5 alone can
stimulate excessive early endosome fusion if expressed at high
enough levels (Horiuchi et al., 1997; Lippe et al., 2001). We
obtained RNAi and UAS lines to examine the effect of Rabex-5 on
early endosome dynamics in the Drosophila wing (VDRC and Yan
et al., 2010). As with RNAi-Rbpn-5, apical Rab5 puncta are sig-
niﬁcantly reduced in RNAi-Rabex-5 expressing tissue (Fig. 4B). We
also observed reduced levels of Rbpn-5 (Fig. 4B), suggesting that as
in vitro, Rabex-5 is required to recruit Rbpn-5 to apical endosomes
in Drosophila. Conversely, over-expression of Rabex-5 causes a
large increase in both size and number of apical and sub-apical
early endosomes (Fig. 4C,G). Furthermore, co-expression of UAS-
Rbpn-5 enhances this phenotype (Fig. 4D,G), indicating that the
two proteins can act together synergistically to promote early
endosome fusion, and suggesting that the inability of UAS-Rbpn-5
to have much effect alone may be due to limiting levels of Rabex-5
normally present in the Drosophila wing. To test the require-
ment for Rbpn-5 in Rabex-5-mediated early endosome fusion,
we removed Rbpn-5 function using RNAi, whilst also expressing
Fig. 2. Rbpn-5 binds to Rab5 in a GTP-dependent manner. GST pulldowns showing
binding of EGFP-Rbpn-5 to GST-tagged Rab proteins on a Gluthathione sepharose
column (see Section Materials and Methods for details). (A,B) EGFP-Rbpn-5 binds
speciﬁcally to GST-Rab5 in the presence of GTP, or to GST-CA-Rab5, a constitutively
active form of the protein, but not to other GST-Rab proteins including Rab4, Rab7
and Rab11 or to a dominant-negative Rab5 (GST-DN-Rab5). Blots were probed with
anti-Rbpn-5, which recognises both Rbpn-5 and (weakly) GST. Smaller bands in A
are variably present and may represent the endogenous Rbpn-5 protein and/or
degradation products that are also pulled down (Rbpn-5 is known to undergo
caspase-dependent cleavage, Cosulich et al., 1997; Swanton et al., 1999). GST bands
appear swollen due to massive amounts of GST-tagged protein on beads loaded
directly onto the gel. The vertical white lines in A indicate empty lanes that were
removed from the image for clarity. (C) Full-length Rbpn-5 (EGFP-Rbpn-5) or the
C-terminal half of Rbpn-5 (EGFP-Rbpn-5-C) bind to GST-Rab5 plus GTP, but the
N-terminal half of Rbpn-5 (EGFP-Rbpn-5-N) does not. The blot was probed with
anti-GFP, which only recognises EGFP-tagged protein. Note there appears to be a
slight shift in the size of EGFP-Rbpn-5-C when pulled down by activated Rab5.
Smaller bands in the EGFP-Rbpn-5-N lane probably represent degradation
products.
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Fig. 3. Rbpn-5 modulates early endosome dynamics in the Drosophilawing. (A–C) Rbpn-5 co-localises with Rab5 in Drosophila early pupal wings. Apically, Rbpn-5 colocalises
with Rab5 in puncta, suggesting that Rbpn-5 localises to early endosomes (A, zoom in C). Medially (B), Rbpn-5 and Rab5 are predominantly cytoplasmic. Rab5 levels are
reduced with little punctate staining and little co-localisation is seen. (D) Expression of RNAi-Rbpn-5 almost eliminates Rbpn-5 staining and strongly reduces apical Rab5
puncta (top half of each image). Subapical Rab5 puncta are not strongly affected. (E) Rbpn-5mutant Ubx-FLP generated clones (marked by an absence of β-Gal in blue) show a
similar reduction in Rbpn-5 staining and loss of apical Rab5 puncta. (F) Over-expressing Rbpn-5 results in a slight increase in number and size of subapical Rab5 puncta (top
half of each image). Apical Rab5 puncta are slightly reduced. In all images (A–F) distal is to the right and anterior is upwards. Rbpn-5 staining is marked in red and Rab5
staining in green. Apart from E, images show an area distal to the posterior crossvein, with the L3 longitudinal wing vein extending horizontally along the centre of the
image. UAS and RNAi constructs are expressed with the ptc-Gal4 driver above L3 (top half of the image), whilst tissue below L3 is wild-type (lower half of the image). UAS-
Dicer2 was co-expressed with RNAi constructs to enhance efﬁcacy. Wings were dissected at 4.5 h APF at 29 1C. Scale bars are 5 μm long. (G-H) Quantiﬁcation of Rab5 vesicle
number and size. Quantiﬁcation and statistical analysis was carried out as described in the Materials and Methods. Mean apical and subapical values for vesicle number and
size were normalised to wild-type before plotting on a graph. Stars indicate statistical difference between wild-type and mutants calculated from the raw data using paired
t-tests. Three stars¼po0.001 and two stars¼po0.01. (H) Quantiﬁcation of RNAi-Rbpn-5 expressing tissue relative to wild-type shows that apical puncta are signiﬁcantly
reduced in both number and size. (I) Quantiﬁcation of UAS-Rbpn-5 expressing tissue relative to wild-type shows that subapical vesicles are signiﬁcantly increased in both
number and size, but that slightly fewer apical vesicles are also present.
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ectopic Rabex-5. Enlargement of early endosomes is still seen to a
similar level as with UAS-Rabex-5 expression alone (Fig. 4E,G),
indicating that excess Rabex-5 has the ability to promote early
endosome fusion even when Rbpn-5 is depleted. We also
expressed a mutant version of Rabex-5 that lacks GEF activity,
UAS-Rabex-5DPYT (Yan et al., 2010). As expected, no increase in
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early endosome size or number is observed and in fact levels of
apical Rab5 puncta are severely reduced (Fig. 4F), indicating that
Rab5 recruitment and early endosome fusion are dependent upon
the GEF activity of Rabex-5. These results are in agreement with
previous work from tissue culture (Horiuchi et al., 1997; Lippe
et al., 2001), and suggest that the Rbpn-5/Rabex-5 complex is
likely to be physically and functionally conserved in Drosophila.
Rabex-5 is a neoplastic tumour suppressor gene
A Rabex-5 hypomorphic mutant has previously been charac-
terised and shown to form giant larvae or pupae, which often
contain melanotic tumours (Yan et al., 2010). Through several
pieces of evidence, these phenotypes have been attributed to
misregulation of Ras signalling, which is known to promote
growth and cause melanotic tumours (Yan et al., 2010; Zettervall
et al., 2004). Rabex-5 regulates Ras signalling not through its GEF
activity, but through a separate ubiquitin ligase domain (Mattera
et al., 2006; Xu et al., 2010; Yan et al., 2010), although since
ubiquitinated cargo including Ras are then targeted to early
endosomes, in practice the two functions of the protein are likely
to be highly interdependent (Aikawa, 2012; Aikawa et al., 2012;
Mattera and Bonifacino, 2008).
Although Ras signalling promotes hyperplastic growth rather than
neoplastic growth, the similarity of the described Rabex-5 mutant
phenotype to that of other endocytic tumour suppressor genes led us
to investigate the mutant animals more closely. As previously
described (Yan et al., 2010), we observed that Rabex-5 homozygous
or Rabex-5/Df(3L)BSC250 transheterozygousmutant larvae grow exces-
sively due to delayed pupation, and contain occasional melanotic
tumours (data not shown). We examined imaginal discs and found
that as for Rbpn-5, the disc epithelium of Rabex-5 mutants is over-
grown and folded, cell size is increased and tissue labels strongly for
Mmp1 expression (Fig. 5A-B). Eye-antennal discs are often fused with
the brain lobes, Elav staining is variable and sometimes completely
absent (e.g. Fig. 5A), and cell division is no longer clearly regulated (Fig.
S4A), indicating that differentiation is compromised. However, again
apico-basal polarity appears to be maintained in Rabex-5 mutants,
Fig. 5. Rabex-5 is a neoplastic tumour suppressor gene. (A) Rabex-5/Df(3L)BSC250 eye discs stained for aPKC, Mmp1 and Elav. Differentiation is absent and Mmp1 levels are
highly upregulated. Anterior is to the left. Scale bar is 50 μm long. (B-C) Wing discs stained with aPKC in red (apical), E-Cad in blue (junctional) and Dlg in green (baso-lateral)
in Rabex-5 mutants. As seen in Rbpn-5, cells have a larger apical surface (B) but apico-basal polarity markers localise correctly at cell edges and show clear separation in a
lateral view (C). Scale bars are 5 μm long. (D) Wild-type (D) and Rabex-5 mutant (D′) wing discs stained for Crb. Laser power and gain was kept at the same level for both
images. Scale bars are 5 μm long. (E) Localisation of markers is normal in Rabex-5 mutant clones visualised in wings at 28 h APF. E-Cad is green and Fmi is red. Clones are
marked by absence of β-Gal staining (blue). Scale bar is 10 μm long.
Fig. 4. Rbpn-5 binds to Rabex-5 and together they modulate early endosome dynamics in vivo. (A) GST pulldown showing binding of EGFP-Rbpn-5 to GST-Rabex-5 on a
Gluthathione agarose column (see Section Materials and Methods for details). The blot was probed with anti-Rbpn5, which recognises EGFP-Rbpn-5 and (weakly) GST. (B)
Expression of RNAi-Rabex-5 strongly reduces Rbpn-5 staining and apical Rab5 puncta (top half of each image). (C) Over-expressing Rabex-5 results in a strong increase in
Rab5 positive vesicles, suggesting that Rabex-5 promotes early endosome fusion. (D) Co-expression of Rabex-5 and Rbpn-5 causes a synergistic increase in Rab5 recruitment
to puncta. (E) Depleting Rbpn-5 activity using RNAi does not reduce the ability of excess Rabex-5 to recruit Rab5 to puncta. (F) Expression of a mutated Rabex-5 that lacks
GEF activity causes a strong reduction in Rab5 puncta, indicating that Rab5 recruitment is dependent upon the GEF activity of Rabex-5. Images B–F are presented as described
for Fig. 3 and scale bars are 10 μm long in all. The over-expression of Myc-tagged Rabex-5 constructs with ptc-Gal4 was veriﬁed by anti-Myc staining in blue. (G)
Quantiﬁcation of Rab5 puncta in the above genotypes. Quantiﬁcation and statistical analysis was carried out as described in Section Materials and Methods. The value of
puncta area is a factor of both puncta number and size. Mean values for puncta area were normalised to wild-type before plotting on a graph. Stars on bars indicate statistical
difference between wild-type and mutants calculated from the raw data using paired t-tests, whereas stars above two bars represent statistical difference between two
mutants, calculated from normalised data using an unpaired t-test. Three stars¼po0.001.
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since clear separation of apical, junctional and baso-lateral markers is
seen and Crb levels are not increased compared with wild-type
(Fig. 5B–D). Ubx-FLP-induced clones lacking Rabex-5 function were
also generated. Cells within clones do not over-proliferate compared to
twin-spots, and tissue appears wild-type with respect to a range of
markers analysed (Fig. 5E and not shown). Together, these results
indicate that Rabex-5 is a neoplastic tumour suppressor gene.
JNK and JAK/STAT pathways are upregulated in Rabex-5 neoplastic
tumours
Drosophila neoplastic tumour phenotypes have been attributed
to several mutually non-exclusive mechanisms. Mis-regulation of
apico-basal polarity due to apical accumulation of Crb protein has
been proposed as key step in tumourigenesis in early endocytic
mutants (Lu and Bilder, 2005; Moberg et al., 2005; Vaccari and
Bilder, 2009). Excess Crb is able to activate the Hippo (Hpo)/Warts
(Wts) signalling pathway, thus promoting growth (Chen et al.,
2010; Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010;
Robinson and Moberg, 2011). However, neither Rbpn-5 nor Rabex-
5 mutant discs exhibit apico-basal polarity defects, and Crb does
not signiﬁcantly accumulate (Figs. 1F–J, 5B–D), indicating that this
mechanism is not obligatory for neoplastic tumour formation.
Hpo/Wts signalling is active throughout mutant discs as shown by
an expanded-lacZ (ex-lacZ) reporter (Fig. S4B, Boedigheimer and
Laughon, 1993), suggesting that this pathway might be contribut-
ing to disc growth. However, the effects are relatively mild and it is
difﬁcult to ascertain whether the broader expression domain
compared to wild-type discs is signiﬁcant or simply a side-affect
of impaired differentiation.
In addition to Crb, other molecules have been found to
accumulate apically in endocytic mutants, and ectopic activity of
many signalling pathways has been documented in neoplastic
tumours, including N, JNK and JAK/STAT. In order to try to
investigate the mechanism of the neoplastic tumour phenotypes
in more detail, we decided to look at the expression of a range of
markers for activation of different signalling pathways. N has been
shown to accumulate apically in early endocytic mutants and in
subapical vesicles in ESCRT mutants, with only the latter resulting
in N pathway activation (Herz et al., 2006,2009; Lu and Bilder,
2005; Moberg et al., 2005; Morrison et al., 2008; Thompson et al.,
2005; Vaccari and Bilder, 2005; Vaccari et al., 2008). ESCRT mutant
clones display a non-autonomous phenotype whereby ectopic N
signalling promotes expression of the JAK/STAT ligand Upd, which
then promotes growth in adjacent wild-type cells (Herz et al.,
2006; Moberg et al., 2005; Vaccari and Bilder, 2005). We do not
observe N accumulation in either Rbpn-5 or Rabex-5 mutant discs
(Figs. 6A-B, S2C), and unsurprisingly, no increase is seen in
expression of the N reporter Gbe-Su(H)-lacZ (Furriols and Bray,
2001, Fig. 6C), indicating that the N pathway is not ectopically
activated. However, we do observe massive upregulation of JAK/
STAT pathway activity in both mutants as assayed using a 10xSTAT-
GFP reporter line (Bach et al., 2007, Figs. 6D, S4C).
In order to test whether JAK/STAT signalling plays an instruc-
tive role in tumourigenesis, we used a hypomorphic stat92E
mutation (Frankenstein—stat92EF) to try to rescue the tumour
phenotype of Rabex-5 mutant discs. stat92EF homozygotes are
Fig. 6. Rabex-5 neoplastic tumours show increased JNK and JAK/STAT pathway activity. Expression of various signalling pathway reporter genes and components in wild-
type (A–E) and Rabex-5mutant (A′–E′) wing discs. In all discs (where possible to tell), anterior is to the left and dorsal is upwards. Scale bars are 50 μm long. (A-B) N protein
localises at a similar intensity to apical junctions and intracellular puncta in both wild-type and Rabex-5 mutant wing discs. (B) shows magniﬁcation of wing pouch area. (C)
GbeþSu(H)-lacZ expression is a read-out for N pathway activity (Furriols and Bray, 2001). A stripe of N activation is seen at the dorso-ventral boundary of the wild-type wing
pouch (C), but no increase in N activity is observable in the Rabex-5mutant wing disc (C′). (D) 10xSTAT-GFP is a read-out for the JAK/STAT pathway activity (Bach et al., 2007).
In wild-type wing discs, a ring of 10xSTAT-GFP is seen around the wing pouch, in the region corresponding to the wing hinge (D). Massive levels of 10xSTAT-GFP are observed
in Rabex-5mutant wing discs (D′). (E) In wild-type wing discs, activated JNK (pJNK) is present at fairly low levels throughout (E), whereas in Rabex-5mutant wing discs, pJNK
levels are increased (E′). (F) A hypomorphic mutation in stat92E rescues various aspects of the neoplastic tumour phenotype as demonstrated by E-Cad staining. Unlike
Rabex-5 single mutant eye discs (F′), Rabex-5, stat92E double mutant eye discs do not invade the brain, are not overgrown or misshapen and ommatidial differentiation
occurs in a fairly wild-type fashion, but tissue is still abnormally folded (F″).
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viable as adults, but produce knobbly outgrowths on the dorsal
prothorax (Baksa et al., 2002 and data not shown). We found that
like Rabex-5 single mutants, Rabex-5, stat92EF homozygotes die
during pupation, but there is no over-growth of either larvae or
imaginal discs (Fig. 6F and data not shown). The tumourous
phenotype of double mutant discs is signiﬁcantly milder than that
of single mutants, as eye-antennal discs are no longer fused to the
brain, but show a relatively wild-type shape and structure,
together with clear signs of differentation (Fig. 6F). However,
abnormal folds are still observed suggesting that not all aspects
of tumourigenesis are downstream consequences of ectopic JAK/
STAT pathway activity.
As Rabex-5 and Rbpn-5 mutants both show upregulation of the
JNK target gene Mmp1 (Figs. 1E, 5A), it appeared likely that ectopic
activation of the JNK pathway could also be contributing to
tumour formation. We tested this using an antibody against
activated (phosphorylated) JNK (pJNK) and indeed found a patchy
accumulation of protein in Rabex-5 and Rbpn-5 mutant discs
(Figs. 6E, S4D-E). In addition, we observed a variable increase in
expression of the JNK lac-Z reporter pucE69 (Martín-Blanco et al.,
1998, Fig. S4F), suggesting that there is a signiﬁcant upregulation
of the JNK pathway in mutant discs, although it does not appear to
be as dramatic as ectopic activation of the JAK/STAT pathway.
In summary, these results suggest that the neoplastic tumour
suppressor phenotypes are linked to activation of JNK and JAK/
STAT pathways, but are not caused by defective N signalling, or
disrupted apico-basal polarity.
Discussion
Rbpn-5 and Rabex-5 are novel tumour suppressor genes
Endocytosis is increasingly recognised as an important
mechanism for the growth and metastasis of tumours, both in
the clinical setting and in cancer models. The categorisation of
endocytic neoplastic tumour suppressor genes in Drosophila began
less than ten years ago with the identiﬁcation of Rab5, avl, Vps25
and Tsg101 (Lu and Bilder, 2005; Moberg et al., 2005; Thompson
et al., 2005; Vaccari and Bilder, 2005) and has since expanded with
the discovery of at least 14 others, in particular multiple compo-
nents of the ESCRT complex (Herz et al., 2009; Menut et al., 2007;
Morrison et al., 2008; Rodahl et al., 2009; Vaccari et al., 2009).
Most mutations so far identiﬁed are zygotic lethal long before the
third instar larval stage and so have been discovered through
screens in which homozygous mutant clones were generated that
spanned entire epithelial compartments in otherwise heterozy-
gous animals. However, not all chromosome arms have been
screened and screens have not been saturating, hence it is likely
that many others remain to be found.
In this study we identify two novel endocytic neoplastic
tumour suppressor genes. Rbpn-5 has not been previously char-
acterised in Drosophila, and our work is the ﬁrst to show that not
only does it act as a neoplastic tumour suppressor gene in
Drosophila, but that its endocytic functions, initially investigated
in mammalian cell culture and in vitro (Stenmark et al., 1995), are
conserved in a multi-cellular organism during development.
Unlike many of the Drosophila endocytic neoplastic tumour
suppressor genes so far identiﬁed, Rbpn-5 has a human homologue
that has been directly implicated in tumour growth and metas-
tasis. Mammalian Rabaptin-5 controls integrin recycling during
migration of invasive tumour cells, has been identiﬁed in patients
suffering from myelomonocytic leukaemia, is involved in prevent-
ing hypoxia in primary kidney and breast tumours and has been
shown to interact physically with the Tuberous sclerosis protein
Tuberin (Christoforides et al., 2012; Magnusson et al., 2001; Wang
et al., 2009; Xiao et al., 1997). Although not all of these functions
may be conserved in Drosophila, our work provides a basis for
further investigating the mechanisms of Rbpn-5 dependent
tumourigenesis in a whole animal system.
Rabex-5 has been previously identiﬁed as a tumour suppressor
gene in Drosophila (Yan et al., 2010), but its neoplastic character-
istics were not described. Importantly, both Rbpn-5 and Rabex-5
mutants are homozygous viable until late larval stages, and thus
may provide a more facile model than other early endocytic
tumour suppressor genes for uncovering the mechanistic basis of
neoplasia.
We had initially set out to identify new regulators of planar
polarity through an RNAi screen. As core planar polarity proteins
are known to undergo internalisation and recycling (Mottola et al.,
2010; Shimada et al., 2006; Strutt and Strutt, 2008; Strutt et al.,
2011), and Rbpn-5 and Rabex-5 are general endocytic regulators
that are functional in epithelial tissues at the time of planar
polarisation, it is highly likely that they are playing a role in
trafﬁcking of core proteins. Indeed, another Rab5 effector, Rbsn-5,
which is also a neoplastic tumour suppressor protein, regulates
Fmi localisation (Morrison et al., 2008; Mottola et al., 2010). Unlike
Rbsn-5, cell-autonomous depletion of Rbpn-5 or Rabex-5 does not
signiﬁcantly alter planar polarity protein levels or localisation
(Figs. 1L, 5E, S3 and data not shown), suggesting that some level
of endocytosis can occur in the absence of these proteins. One
possibility is that Rbpn-5 and Rabex-5 proteins might be highly
stable compared with Rbsn-5. Evidence in support of this comes
from zygotic mutants, which survive to early pupal stages for
Rbpn-5 and Rabex-5 (Fig. 1B, Yan et al., 2010), presumably due to
perdurance of maternal protein, but die before the second larval
instar in the Rbsn-5 background (Morrison et al., 2008). If this is
the case, residual protein activity in clones or RNAi-treated tissue
may allow a low level of general endocytosis to occur, which
would be sufﬁcient to correctly localise core planar polarity
proteins. Another, non-mutually exclusive hypothesis is that a
level of endocytosis can occur in the absence of either Rabex-5 or
Rbpn-5. There are three other Rab5 GEF homologues in Drosophila
(Smythe, unpublished data), and these may be able to step in if
Rabex-5 is absent.
Whatever the reason may be, the lack of defects seen in clones
or RNAi, combined with the severe pleiotropic effects on epithelial
architecture observed in zygotic mutants (Figs. 1C,E, 5A, and S2),
means that analysis of a speciﬁc role in planar polarity is
extremely complex and we decided to focus our attentions on
their tumour suppressor roles.
The Rab5 effector function of Rabaptin-5 is conserved in drosophila
In mammalian cells, it has been shown that Rabaptin-5 is an
effector of Rab5 that promotes early endosome fusion through its
interaction with Rabex-5 (Horiuchi et al., 1997; Lippe et al., 2001;
McBride et al., 1999; Stenmark et al., 1995; Vitale et al., 1998). We
provide here the ﬁrst characterisation of a Rabaptin-5 homologue
in a multicellular organism, and show that many of its functions
are conserved. Rab5 effectors are deﬁned by several criteria
including GTP-dependent binding to Rab5 and the ability to
modulate a Rab5-dependent process in response to Rab5 activity.
We show here that Drosophila Rbpn-5 fulﬁls the criteria of a Rab5
effector protein in the same way as its mammalian counterpart.
Firstly we have demonstrated that Rbpn-5 physically interacts
speciﬁcally with GTP-bound Rab5, probably through its predicted
C-terminal Rab5 binding domain. Secondly, that Rbpn-5 and Rab5
colocalise in Drosophila pupal wings. Thirdly, when we deplete
Rbpn-5 using RNAi or in mutant clones, we see a strong reduction
in apical Rab5-positive vesicles indicating that Rbpn-5 is required
for Rab5 recruitment. Lastly, if we over-express Rbpn-5 we observe
C. Thomas, D. Strutt / Developmental Biology 385 (2014) 107–121 117
subtle alterations in early endosome structure, which are indica-
tive of a role for Rbpn-5 in promoting early endosome fusion.
Although the Rab5 effector function of Rabaptin-5 is conserved in
Drosophila, its Rab4 effector function may not be. Mammalian
Rabaptin-5 has been shown to bind Rab4 through a separate N-
terminal domain, and the divalent Rab5-Rab4 binding ability allows
Rbpn-5 to act as a bridge between the endocytic and fast recycling
pathways (Daro et al., 1996; van der Sluijs et al., 1992; Vitale et al.,
1998). We were not able to recapitulate Rab4 binding, and indeed the
N-terminal Rab4 binding site is not highly conserved in Drosophila
Rbpn-5. A similar result was found for the Drosophila homologue of
another Rab5-Rab4 divalent effector, Rabenosyn-5 (Morrison et al.,
2008), suggesting that the mechanism of transfer of cargo from the
endocytic to recycling routes might not be conserved across phyla.
The interaction between Rabaptin-5 and Rabex-5 is conserved in
drosophila
A large number of proteins have been shown to bind Rabaptin-
5, but one of the best characterised is Rabex-5. The endogenous
GEF activity of Rabex-5 is fairly low, and unless large quantities are
overexpressed, the formation of a Rabaptin-5/Rabex5 complex is
necessary to promote nucleotide exchange on Rab5 (Esters et al.,
2001; Horiuchi et al., 1997; Lippe et al., 2001; Zhu et al., 2007). The
effect of this is to enhance Rab5 activity, thus facilitating its
recruitment of factors involved in tethering and fusion of early
endocytic membranes.
Here we provide evidence that the interaction between Rabex-
5 and Rbpn-5, and their ability to alter early endosome dynamics
is conserved in Drosophila. As with their mammalian counterparts,
the two proteins bind in vitro: we suspect that Rabex-5 binds to a
central domain in Rbpn-5, as this is homologous to the Rabex-5
binding site in mammalian Rabaptin-5 (Mattera et al., 2006), and
neither N- nor C-termini of Rbpn-5 can bind alone. As in
mammalian cells (Horiuchi et al., 1997; Zhu et al., 2007), over-
expression of Rabex-5 in Drosophila wings is sufﬁcient to promote
early endosome fusion even if Rbpn-5 levels are depleted by RNAi.
However, co-expression of Rbpn-5 signiﬁcantly enhances this,
demonstrating that the complex acts synergistically. The depen-
dency on Rabex-5 for Rabaptin-5 localisation to early endosomes
is also conserved in Drosophila as we show that depletion of
Rabex-5 levels using RNAi causes a reduction in Rbpn-5 puncta.
This is surprising as not only does Rbpn-5 contain a Rab5 binding
domain, but also a FYVE domain (unlike its mammalian homo-
logue), which would be expected to promote its recruitment to
early endosomes. It is possible that the FYVE domain is non-
functional. Alternatively, its ability to bind PI3P may be somehow
inhibited in the absence of Rabex-5, or the protein may be
destabilised. Further work would be required to distinguish
between these possibilities.
We found that over-expressing a mutant form of Rabex-5
lacking GEF activity (Yan et al., 2010) prevents both Rbpn-5 and
Rab5 from accumulating in apical puncta. We surmise that the
construct is acting in a dominant-negative manner to suppress
Rbpn-5 recruitment and/or Rab5 activation via endogenous Rabex-
5. In mammalian cells, localisation of all three proteins appears to
be highly interdependent, suggesting that it is likely that Rabex-5
recruitment to early endosomes is also compromised in the
absence of Rbpn-5 or Rab5. However, in the absence of reagents
for visualising endogenous Rabex-5, this remains speculative.
Rbpn-5 and Rabex-5 neoplastic discs do not show disrupted
apico-basal polarity
The mechanistic basis of neoplastic tumour formation is com-
plex and much remains unclear. Drosophila models, in particular
the classic baso-lateral polarity complex mutants scrib, dlg and lgl,
which were discovered many years ago and which, unlike most of
the endocytic mutants, are zygotically viable until late larval
stages, have been extremely useful in describing the process of
tumorigenesis (Bilder et al., 2000; Bilder and Perrimon, 2000;
Bryant and Schubiger, 1971; Gateff, 1978; Gateff and
Schneiderman, 1967; reviewed in Enomoto and Igaki, 2011). There
are several different pathways and mechanisms that have been
investigated. Given that Scrib, Dlg and Lgl regulate apico-basal
polarity by inhibiting the apical Crb and Par-3/Bazooka (Baz)
complexes (Betschinger et al., 2003; Bilder et al., 2003;
Tanentzapf and Tepass, 2003), an expansion of the apical domain
was proposed as one possible mechanism for tumourigenesis. This
hypothesis was reinforced by the ﬁnding that over-expressing
either Crb or atypical Protein kinase C (aPKC) is sufﬁcient to
promote tumourous discs, and that in the endocytic mutants,
Crb accumulates massively and apico-basal polarity is disrupted
(Bilder and Perrimon, 2000; Leong et al., 2009; Lu and Bilder,
2005; Moberg et al., 2005; Vaccari and Bilder, 2005). Crb accu-
mulation is thought to promote the growth aspect of the neoplas-
tic tumour phenotype through misregulation of the Hpo/Wts
pathway (Chen et al., 2010; Grzeschik et al., 2010; Ling et al.,
2010; Robinson et al., 2010; Robinson and Moberg, 2011). How-
ever, there is some evidence that Crb is not always strongly
misregulated in neoplastic tumours, and it has been speculated
that in scrib, dlg and lgl mutants it may be the concurrent
disruption of endocytosis, rather than the polarity defect, which
is the primary cause of their neoplastic phenotypes (Leong et al.,
2009; Robinson and Moberg, 2011).
Our results show that neither Rabex-5 nor Rbpn-5 exhibit
disruption in apico-basal polarity and there is no accumulation
of Crb (Figs. 1F-J, 5B-D). We suggest that these mutants are likely
to represent a milder phenotype than the other endocytic mutants
studied so far, possibly due to enhanced perdurance of maternal
protein which allows the survival of zygotic mutants to early pupal
stages. In any case, the lack of an apico-basal polarity defect in
Rbpn-5 and Rabex-5 mutants indicates that loss of apico-basal
polarity is not strictly required for neoplasia.
Mechanisms of neoplastic tumour formation in Rbpn-5 and Rabex-5
mutants
Other pathways that have been found to be activated in
Drosophila neoplastic tumours include N, JAK/STAT and JNK. Due
to the differential ability of N to signal in different endocytic
compartments, the pathway is upregulated in ESCRT mutant
tumours, but not in early endocytic mutants, despite their accu-
mulation of N protein on the cell surface (Herz et al., 2006; Herz
et. al., 2009; Lu and Bilder, 2005; Moberg et al., 2005; Morrison
et al., 2008; Thompson et al., 2005; Vaccari and Bilder, 2005;
Vaccari et al., 2008). As with Crb, we do not observe accumulation
of N in Rbpn-5 or Rabex-5 mutant discs (Figs. 6A-B, and S2C),
suggesting that a certain level of endocytosis is still occurring, and
unsurprisingly we also ﬁnd that the N pathway is not activated.
In ESCRT mutant clones, activation of the N pathway leads to
transcription of the JAK/STAT ligand Upd, which acts non-
autonomously on wild-type tissue to induce JAK/STAT signalling
and promote neoplasia (Herz et al., 2006; Moberg et al., 2005;
Vaccari and Bilder, 2005). The massive upregulation of JAK/STAT
signalling that we observe must be activated via an alternate
mechanism, as it is both cell autonomous and N-independent.
Although autonomous JAK/STAT signalling in neoplastic discs has
been documented and shown to contribute to excessive cell size
and proliferation (Gilbert et al., 2009; Woodﬁeld et al., 2013), it is
unclear how it is activated in endocytic mutants. One explanation
that we were unable to test, is that the endocytic block could
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directly disrupt the trafﬁcking of the JAK/STAT receptor Domeless
(Dome), as Dome localisation has been shown to be altered in
ESCRT mutant neoplastic tumourous discs (Gilbert et al., 2009),
and signalling ability is known to be inﬂuenced by the intracellular
compartment in which the ligand-receptor complex ﬁnds itself
(Devergne et al., 2007; Vidal et al., 2010). We show that a
hypomorphic stat92E mutation is able to rescue many of the
neoplastic defects, including over-proliferation, inability to differ-
entiate and overall disc shape and structure, suggesting that
ectopic activation of JAK/STAT signalling in endocytic mutants is
indeed causative for these aspects of tumourigenesis.
The upregulation of the JNK pathway that we observe in the
Rbpn-5 and Rabex-5 mutants is likely to also contribute to the
over-proliferation phenotype. The JNK pathway is unusual in
having both pro-proliferation and pro-apoptotic roles, and was
initially thought to be activated only where wild-type tissue abuts
clones mutant for neoplastic tumour suppressor genes, promoting
apoptosis within mutant cells and their elimination from the
tissue (Brumby and Richardson, 2003; Igaki et al., 2006, 2009;
Ohsawa et al., 2011; Uhlirova et al., 2005). However, more recent
work has shown that JNK signalling is also activated in tissues
wholly mutant for endocytic neoplastic tumour suppressor genes
where it promotes cell proliferation (Woodﬁeld et al., 2013).
It is thought that JNK pathway upregulation in neoplastic
tumours is likely to act through the Eiger/TNF ligand receptor
complex (Igaki et al., 2002, 2009; Moreno et al., 2002). Eiger and
activated JNK have been shown to accumulate in early endosomes
in scrib mutant clones to promote apoptosis, and there are several
other pieces of evidence that implicate the endocytic pathway in
Eiger regulation (Igaki et al., 2009). Interestingly, the switch from
JNK-mediated apoptosis to proliferation can be mediated by co-
expression of the Ras oncogene. For example, expressing Ras in
scrib mutant clones produces a highly invasive neoplastic pheno-
type such that clones that would usually be eliminated instead
invade neighbouring wild-type tissue (Brumby and Richardson,
2003; Doggett et al., 2011; Igaki et al., 2006; Pagliarini and Xu,
2003; Uhlirova et al., 2005; Wu et al., 2010). Given that Ras is
ubiquitinated by Rabex-5, and the Ras pathway has been shown to
be upregulated in Rabex-5mutant larvae (Xu et al., 2010; Yan et al.,
2010), it is intriguing to speculate whether this may be contribut-
ing in some way to the neoplastic phenotype seen in mutant larval
discs, not only in the Rabex-5 background but perhaps more
generally in other endocytic neoplastic tumour suppressor
mutants. Indeed, as Rabex-5-mediated ubiquitination targets
cargo to early endosomes for degradation (Aikawa, 2012; Aikawa
et al., 2012; Mattera and Bonifacino, 2008; Mattera et al., 2006), it
seems highly likely that Ras signalling is not only regulated by
ubiquitination but also by endosomal dynamics. Further work will
be needed to investigate a potential role for Ras in endocytic
neoplastic tumours, to determine the mechanisms of JNK and JAK/
STAT activation and to elucidate how differential activity of these
pathways is controlled in clones versus whole mutant tissues.
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